![](/img/cover-not-exists.png)
Efficacy of peginterferon ALFA-2A (40KD) (PEGASYS) plud ribavirin for 24 weeks in genotype 1 patients with chronic hepatitis C followed by mono or combination therapy for 22 weeks: Preliminary analysis of an open, multicenter, randomized trial
J.P. Bronowicki, D. Ouzan, T. Asselah, H. Desmorat, J.P. Zarski, J. Foucher, M. Bourliere, C. Renous, A. Tran, P. Melin, C. Hezode, M. Chevallier, M. Bouvier, J.M. Pawlotsky, I. Lonjon-DomanecVolume:
38
Year:
2003
Language:
english
DOI:
10.1016/s0168-8278(03)80467-1
File:
PDF, 278 KB
english, 2003